Home
>
National Drug Code (NDC)
>
Condylox
Condylox - 52544-045-13 - (podofilox)
Drug Information of Condylox
| Product NDC: | 52544-045 |
| Proprietary Name: | Condylox |
| Non Proprietary Name: | podofilox |
| Active Ingredient(s): | 5 mg/g & nbsp; podofilox |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Condylox
| Product NDC: | 52544-045 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020529 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970313 |
Package Information of Condylox
| Package NDC: | 52544-045-13 |
| Package Description: | 3.5 g in 1 TUBE, WITH APPLICATOR (52544-045-13) |
NDC Information of Condylox
| NDC Code | 52544-045-13 |
| Proprietary Name | Condylox |
| Package Description | 3.5 g in 1 TUBE, WITH APPLICATOR (52544-045-13) |
| Product NDC | 52544-045 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | podofilox |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 19970313 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | PODOFILOX |
| Strength Number | 5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Mitosis [PE] |
